Oscar Health Navigates Q2 Loss, Targets 2026 Profitability
Oscar Health's Q2 2025 showed a $228M loss due to sicker patients. CEO Mark Bertolini aims for 2026 profitability.
Feed↓
/ What's going on?
Filter:
Opendoor Q2 2025: Profitability Amidst Market Deterioration
Opendoor sees Q2 Adjusted EBITDA profit, but forecasts Q3 decline. Shifts to agent-led, capital-light models due to market. Opendoor aims to leverage its recent meme stock "increased visibility".
Snap Q2 2025: Ad Glitch Impacts Revenue, User Growth Strong
Snap's Q2 revenue missed estimates due to an ad platform glitch & policy changes. User growth and Snapchat+ remain strong points.
AMD AI: Growth Trajectory Meets China Hurdles
AMD's Q3 revenue outlook is strong, but China AI chip sales face uncertainty as licenses are under review.
Novo Nordisk Navigates US Market Headwinds & Leadership Shift
Novo Nordisk faces slowing growth, fierce competition from Eli Lilly and copycats in the US, prompting a CEO change and strategic refocus.
Yum! Brands Q2 Challenges & Strategic Response
Yum! Brands missed Q2 targets due to rising costs and soft demand. Taco Bell slowed, KFC/Pizza Hut saw declines. Value deals and AI are key strategies.